Study of antibody to treat mesothelioma

An antibody developed to stop the growth of mesothelin is currently being studied. Mesothelin is a protein that is overproduced in tumors present in mesothelioma patients.

The antibody blocks the function of mesothelin. Mesothelin is thought to advance the metastasis of mesothelioma tumors. Preclinical data indicates that the antibody will prevent mesothelin from interacting with its target and stimulate the patient’s immune system to attack the tumor.

If you or a loved one has been diagnosed with an asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.